Your browser is no longer supported. Please, upgrade your browser.
TELA Bio, Inc.
Index- P/E- EPS (ttm)-2.35 Insider Own7.08% Shs Outstand14.42M Perf Week-3.00%
Market Cap243.45M Forward P/E- EPS next Y-1.77 Insider Trans4.75% Shs Float12.80M Perf Month10.14%
Income-28.50M PEG- EPS next Q-0.49 Inst Own83.70% Short Float1.02% Perf Quarter2.06%
Sales17.40M P/S13.99 EPS this Y2.60% Inst Trans-0.46% Short Ratio5.62 Perf Half Y10.91%
Book/sh3.91 P/B4.06 EPS next Y18.40% ROA-36.00% Target Price20.00 Perf Year9.00%
Cash/sh5.31 P/C2.99 EPS next 5Y- ROE-65.10% 52W Range5.25 - 23.55 Perf YTD5.45%
Dividend- P/FCF- EPS past 5Y- ROI-31.30% 52W High-32.26% Beta-
Dividend %- Quick Ratio15.90 Sales past 5Y- Gross Margin60.50% 52W Low203.81% ATR0.96
Employees89 Current Ratio16.70 Sales Q/Q32.50% Oper. Margin- RSI (14)54.01 Volatility7.38% 5.63%
OptionableNo Debt/Eq0.55 EPS Q/Q9.40% Profit Margin- Rel Volume0.41 Prev Close15.86
ShortableYes LT Debt/Eq0.55 Earnings- Payout- Avg Volume23.32K Price15.95
Recom1.50 SMA203.73% SMA505.84% SMA2004.14% Volume6,000 Change0.57%
Dec-03-19Initiated Piper Jaffray Overweight
Dec-03-19Initiated JMP Securities Mkt Outperform
Dec-03-19Initiated Jefferies Buy
Dec-03-19Initiated Canaccord Genuity Buy
Mar-02-21 07:00AM  
Feb-12-21 05:16AM  
Feb-04-21 07:00AM  
Jan-14-21 07:00AM  
Jan-06-21 07:00AM  
Jan-05-21 07:00AM  
Dec-09-20 01:32PM  
Nov-24-20 07:00AM  
Nov-11-20 04:34PM  
Nov-10-20 07:00AM  
Oct-21-20 04:05PM  
Sep-25-20 07:00AM  
Sep-02-20 07:00AM  
Aug-12-20 04:05PM  
Jul-30-20 07:00AM  
Jul-23-20 05:19PM  
Jun-30-20 04:05PM  
Jun-25-20 06:42PM  
Jun-24-20 08:07AM  
Jun-23-20 09:35PM  
Jun-22-20 07:00AM  
Jun-15-20 07:00AM  
May-29-20 07:00AM  
May-12-20 04:05PM  
Apr-28-20 07:00AM  
Apr-23-20 06:30AM  
Mar-30-20 07:29AM  
Mar-27-20 07:00AM  
Mar-11-20 07:00AM  
Feb-04-20 04:15PM  
Jan-29-20 07:00AM  
Jan-10-20 07:00AM  
Dec-18-19 07:00AM  
Dec-06-19 07:00AM  
Nov-13-19 04:15PM  
Nov-08-19 06:17PM  
Nov-07-19 08:00PM  
TELA Bio, Inc., a medical technology company, focuses on the design, development, and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was founded in 2012 and is headquartered in Malvern, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
EW HEALTHCARE PARTNERS FUND 2,Feb 04Buy14.292,82240,3261,524,578Feb 23 12:47 PM
EW HEALTHCARE PARTNERS FUND 2,Feb 02Buy14.082503,5201,521,756Feb 23 12:47 PM
EW HEALTHCARE PARTNERS FUND 2,Feb 01Buy14.161,11915,8451,521,506Feb 23 12:47 PM
EW HEALTHCARE PARTNERS FUND 2,Jan 29Buy13.937,760108,0971,520,387Feb 23 12:47 PM
EW HEALTHCARE PARTNERS FUND 2,Jan 28Buy13.6813,950190,8361,512,627Feb 23 12:47 PM
EW HEALTHCARE PARTNERS FUND 2,Jan 27Buy14.035,00070,1501,498,677Feb 23 12:47 PM
EW HEALTHCARE PARTNERS FUND 2,Jan 26Buy14.241,54421,9871,493,677Feb 23 12:47 PM
EW HEALTHCARE PARTNERS FUND 2,Jan 15Buy13.8876310,5901,492,133Feb 23 12:47 PM
EW HEALTHCARE PARTNERS FUND 2,Jan 14Buy13.969,075126,6871,491,370Feb 23 12:47 PM
EW HEALTHCARE PARTNERS FUND 2,Jan 13Buy13.907,00297,3281,482,295Feb 23 12:47 PM